SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Booms, Busts, and Recoveries -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (49188)4/30/2004 1:45:22 PM
From: Henry Niman  Read Replies (1) | Respond to of 74559
 
Medarex has sent a monoclonal antibody to Beijing and Agouron is working on a protease inhibitor. Others are working on vaccine development and diagnostic tests.



To: LLCF who wrote (49188)4/30/2004 3:31:22 PM
From: keokalani'nui  Respond to of 74559
 
SinoVac is fast with a vaccine candidate, but as with contemporary chinese capitalism in general the company comes with some hair on it.

Wilder (no position)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News